Concurrent Acute Monoblastic Leukemia and Multiple Myeloma in a 66-Year-Old Chemotherapy-Naive Woman
Srujitha Murukutla, Swaty Arora, Vijaya Raj Bhatt, Shiksha Kedia, Muhammad Popalzai, Meekoo Dhar
Abstract
Concurrent acute myeloid leukemia (AML) and multiple myeloma (MM) is rare, more so in chemotherapy-naive patients. Concurrent occurrence of these two malignancies portends poor prognosis. Although anthracycline-based AML regimen, allogeneic hematopoietic stem cell transplantation, tipifarnib and bortezomib have shown promising results in small number of patients, there is a lack of established therapy. We describe a case of concurrent AML and MM in a 66-year-old woman and review previously published literature.
World J Oncol. 2014;5(2):68-71
doi: http://dx.doi.org/10.14740/wjon722w
Keywords
Acute myeloid leukemia; Multiple myeloma; Chemotherapy
Full Text:
HTML
PDF